Dr Anthony Newall is an Associate Professor in Health Economics at the School of Population Health, UNSW Sydney. His research focuses on the economic evaluation (cost-effectiveness) of vaccines and other infectious disease prevention strategies, drawing on mathematical modelling and epidemiological and statistical analyses. His work addresses policy questions in Australia and internationally.

He has authored more than 100 publications in peer-reviewed journals. Based on publications indexed in Scopus (2026), he has published more articles on vaccine economics than any other Australian-based researcher, and his publication record is among the most extensive in the field internationally. His research spans a wide range of vaccines and infectious diseases, including influenza, pneumococcal disease, rotavirus, COVID-19 and respiratory syncytial virus, among others. His interests also include methodological research in vaccine economics, such as the integration of economic evaluation with dynamic transmission models and equity-informative economic evaluation.

Anthony was the lead author of the World Health Organization (WHO) Guidance on the economic evaluation of influenza vaccination and co-authored the companion WHO Manual for estimating the economic burden of seasonal influenza. He has also served on the WHO Technical Advisory Group for the Full Value of Improved Influenza Vaccine Assessment (FVIVA), which examined the potential public health, economic and societal value of improved seasonal influenza vaccines. He was previously appointed to the WHO Roster of Experts in Health Economics.

He has also been an Honorary Fellow at the National Centre for Immunisation Research and Surveillance (NCIRS), a Visiting Associate Professor at Columbia University and a Visiting Scholar at the US National Institutes of Health. He holds a Master of Public Health (Honours) and a PhD from the University of Sydney, where his PhD research focused on the cost-effectiveness of vaccination. His awards include the Bernie J. O’Brien New Investigator Award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Aileen Plant Memorial Prize and the UNSW Faculty of Medicine Dean’s Rising Star Award.

Prospective PhD students interested in mathematical modelling, health economics, cost-effectiveness analysis, economic evaluation, statistical or epidemiological projects should contact him via email. PhD projects available require strong quantitative skills although other types of projects may be available for prospective ILP or Master's students.